Pallas Capital Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Buy |
22,275
+1,127
| +5% | +$29.9K | 0.02% | 450 |
|
|
2025
Q1 | $511K | Sell |
21,148
-92
| -0.4% | -$2.22K | 0.02% | 457 |
|
|
2024
Q4 | $855K | Sell |
21,240
-165
| -0.8% | -$6.64K | 0.04% | 264 |
|
|
2024
Q3 | $1.57M | Buy |
21,405
+2,062
| +11% | +$151K | 0.07% | 167 |
|
|
2024
Q2 | $969K | Buy |
19,343
+4,426
| +30% | +$222K | 0.04% | 216 |
|
|
2024
Q1 | $1.22M | Buy |
14,917
+551
| +4% | +$45.2K | 0.05% | 193 |
|
|
2023
Q4 | $267K | Buy |
14,366
+917
| +7% | +$17.1K | 0.01% | 327 |
|
|
2023
Q3 | $129K | Hold |
13,449
| – | – | 0.01% | 337 |
|
|
2023
Q2 | $208K | Buy |
+13,449
| New | +$208K | 0.01% | 251 |
|